David Miller

5.5k total citations · 1 hit paper
109 papers, 3.2k citations indexed

About

David Miller is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Epidemiology. According to data from OpenAlex, David Miller has authored 109 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Ophthalmology, 35 papers in Radiology, Nuclear Medicine and Imaging and 15 papers in Epidemiology. Recurrent topics in David Miller's work include Intraocular Surgery and Lenses (24 papers), Retinal Diseases and Treatments (20 papers) and Glaucoma and retinal disorders (19 papers). David Miller is often cited by papers focused on Intraocular Surgery and Lenses (24 papers), Retinal Diseases and Treatments (20 papers) and Glaucoma and retinal disorders (19 papers). David Miller collaborates with scholars based in United States, Switzerland and Philippines. David Miller's co-authors include Robert Stegmann, Adam R. Glassman, Roy W. Beck, Frederick L. Ferris, Lloyd Paul Aiello, Allison R. Edwards, Neil M. Bressler, Jennifer K. Sun, Scott M. Friedman and Cynthia R. Stockdale and has published in prestigious journals such as PEDIATRICS, Ophthalmology and The Journal of Pediatrics.

In The Last Decade

David Miller

93 papers receiving 2.9k citations

Hit Papers

Randomized Trial Evaluating Ranibizumab Plus Prompt or De... 2010 2026 2015 2020 2010 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Miller United States 25 2.2k 1.8k 397 322 285 109 3.2k
Andrew Hamilton United Kingdom 27 1.2k 0.5× 722 0.4× 253 0.6× 80 0.2× 274 1.0× 111 2.2k
David J. Browning United States 31 3.7k 1.7× 3.0k 1.7× 178 0.4× 93 0.3× 378 1.3× 94 4.3k
Chi‐Chun Lai Taiwan 32 3.1k 1.4× 2.9k 1.6× 706 1.8× 251 0.8× 647 2.3× 287 4.8k
James P. Ganley United States 17 2.0k 0.9× 1.2k 0.7× 591 1.5× 151 0.5× 550 1.9× 46 2.8k
Ron A. Adelman United States 39 4.2k 1.9× 3.3k 1.8× 285 0.7× 246 0.8× 776 2.7× 131 5.1k
Z. N. Zakov United States 27 942 0.4× 377 0.2× 228 0.6× 60 0.2× 225 0.8× 112 2.0k
Michael Mimouni Israel 27 1.6k 0.7× 1.6k 0.9× 486 1.2× 601 1.9× 117 0.4× 244 2.6k
Colin S. Tan Singapore 33 3.2k 1.4× 2.2k 1.2× 494 1.2× 247 0.8× 154 0.5× 108 3.8k
Nicola Brown United Kingdom 24 737 0.3× 580 0.3× 348 0.9× 304 0.9× 480 1.7× 60 1.8k
Kah‐Guan Au Eong Singapore 31 2.2k 1.0× 1.4k 0.8× 996 2.5× 210 0.7× 238 0.8× 133 3.0k

Countries citing papers authored by David Miller

Since Specialization
Citations

This map shows the geographic impact of David Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Miller more than expected).

Fields of papers citing papers by David Miller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Miller. The network helps show where David Miller may publish in the future.

Co-authorship network of co-authors of David Miller

This figure shows the co-authorship network connecting the top 25 collaborators of David Miller. A scholar is included among the top collaborators of David Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Miller. David Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Miller, David, et al.. (2023). Real-World Frequency and Management of Ocular Adverse Events in Eyes with Neovascular Age-Related Macular Degeneration Treated with Brolucizumab. Ophthalmology and Therapy. 12(5). 2397–2408. 4 indexed citations
3.
Coney, Joseph, Thomas D. Hull, David Miller, et al.. (2023). One-Year and 18-Month Outcomes in nAMD Patient Eyes Switched to Brolucizumab Alone versus to Brolucizumab Alternating with Other Anti-VEGF Agents. Clinical ophthalmology. Volume 17. 3601–3611. 1 indexed citations
4.
Abdulaal, Marwan, et al.. (2023). Early surgical displacement of submacular hemorrhage without tissue plasminogen activator use: one-year outcomes. Canadian Journal of Ophthalmology. 59(5). e582–e589. 1 indexed citations
5.
Miller, David, et al.. (2021). The effect of patient facemask usage on post-injection endophthalmitis among intravitreally injected patients in Ohio from 2019-2020. Investigative Ophthalmology & Visual Science. 62(8). 1369–1369. 1 indexed citations
6.
Miller, Alexander, et al.. (2021). Preoperative telephone medical clearance for ophthalmic surgeries. Journal of Cataract & Refractive Surgery. 47(11). 1485–1486. 1 indexed citations
7.
Chandra, Rohit, David Miller, Lawrence J. Singerman, et al.. (2019). Surgical Outcomes and Patient Satisfaction in Vitrectomy for Vitreous Floaters. Investigative Ophthalmology & Visual Science. 60(9). 5783–5783. 1 indexed citations
8.
Liu, John, et al.. (2018). Fluocinolone acetonide (FAc) 0.2 mg intravitreal implant in the treatment of diabetic macular edema (DME). Investigative Ophthalmology & Visual Science. 59(9). 4816–4816. 1 indexed citations
9.
Zegarra, Hernando, Z. N. Zakov, Michael Novák, et al.. (2016). The use of anti-vascular endothelial growth factor therapies in the macular telangiectasia associated with choroidal neovascularization.. Investigative Ophthalmology & Visual Science. 57(12). 2145–2145. 1 indexed citations
10.
Miller, David. (2012). Exploratory Analysis of Diabetic Retinopathy Worsening (Progression) at 1 Year and 3 Years in a Randomized Clinical Trial Evaluating Ranibizumab and Triamcinolone. Investigative Ophthalmology & Visual Science. 53(14). 366–366. 1 indexed citations
11.
Coney, Joseph, et al.. (2011). Pegaptanib octasodium for the treatment of diabetic macular edema. Expert Opinion on Pharmacotherapy. 12(8). 1317–1323. 2 indexed citations
12.
Aiello, Lloyd Paul, Allison R. Edwards, Roy W. Beck, et al.. (2010). Factors Associated with Improvement and Worsening of Visual Acuity 2 Years after Focal/Grid Photocoagulation for Diabetic Macular Edema. Ophthalmology. 117(5). 946–953. 77 indexed citations
13.
Miller, David & Lawrence J. Singerman. (2006). Vision Loss in Younger Patients: A Review of Choroidal Neovascularization. Optometry and Vision Science. 83(5). 316–325. 33 indexed citations
14.
Pistilli, Emidio E., et al.. (2004). An 8-Week Periodized Mesocycle Leading to a National Level Weightlifting Competition. Strength and conditioning journal. 26(5). 62–62. 4 indexed citations
15.
Pistilli, Emidio E., et al.. (2004). An 8-Week Periodized Mesocycle Leading to a National Level Weightlifting Competition. Strength and conditioning journal. 26(5). 62–68. 3 indexed citations
16.
Miller, David, et al.. (1999). Flight Simulation As A Tool To Develop V-22 Slung Load Capabilities. 2 indexed citations
17.
Martidis, Adam, David Miller, Thomas A. Ciulla, Ronald P. Danis, & Ramana S. Moorthy. (1999). Corticosteroids as an Antiangiogenic Agent for Histoplasmosis-Related Subfoveal Choroidal Neovascularization. Journal of Ocular Pharmacology and Therapeutics. 15(5). 425–428. 57 indexed citations
18.
Miller, David, Peter Lou, Arnold J. Kroll, & Edward A. Ryan. (1999). Surgical Management of Macular Hole. International Ophthalmology Clinics. 39(1). 261–274. 2 indexed citations
19.
Miller, David, et al.. (1990). Effect of intraocular lens decentration on retinal image contrast. Journal of Cataract & Refractive Surgery. 16(6). 712–714. 12 indexed citations
20.
Hall, Caroline B. & David Miller. (1969). The detection of a silent coxsackie B-5 virus perinatal infection. The Journal of Pediatrics. 75(1). 124–127. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026